# Efficacy and Safety of Thoracoscopic Morrow Surgery in the Treatment of Hypertrophic Obstructive Cardiomyopathy

> **NCT06391788** · NA · UNKNOWN · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 132 (estimated)

## Conditions studied

- Cardiomyopathy, Hypertrophic Obstructive
- Minimally Invasive Surgery

## Interventions

- **PROCEDURE:** thoracoscopic Morrow surgery
- **PROCEDURE:** modified Morrow surgery

## Key facts

- **NCT ID:** NCT06391788
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-31
- **Primary completion:** 2025-02-01
- **Final completion:** 2025-03-31
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2024-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06391788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06391788, "Efficacy and Safety of Thoracoscopic Morrow Surgery in the Treatment of Hypertrophic Obstructive Cardiomyopathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06391788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*